Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: An in vivo electrochemical study

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 455-463

  Hoffman, Alexander F ^a   Gerhardt, Greg A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINE RELEASE; ELECTROCHEMICAL DETECTION; ELECTROCHEMISTRY; NERVE CONDUCTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SUBSTANTIA NIGRA;

ANIMALS; CADMIUM; CALCIUM; COCAINE; DOPAMINE; DOPAMINE ANTAGONISTS; ELECTROCHEMISTRY; NEOSTRIATUM; OXIDATION-REDUCTION; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA; SULPIRIDE; TETRODOTOXIN;

EID: 0032925118     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Abarca J, Gysling K, Roth RH and Bustos G (1995) Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: In vivo microdialysis studies. Neurochem Res 20:159-169.
2. Aceves J, Floran B, Sierra A and Mariscal S (1995) D-1 receptor mediated modulation of the release of gamma-aminobutyric acid by endogenous dopamine in the basal ganglia of the rat. Prog Neuropsychopharmacol Biol Psych 19:727-739.
3. Bergquist F, Jonason J, Pileblad E and Nissbrandt H (1998) Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: A microdialysis study in rat. J Neurochemistry 70:1532-1540.
4. Bjorklund A and Lindvall O (1975) Dopamine in dendrites of substantia nigra neurons: Suggestions for a role in dendritic terminals. Brain Res 83:531-537.
5. Bradbury AJ, Costall B and Naylor RJ (1983) Reduction in motor responding of the mouse by actions of dopamine agonists in the midbrain. Neuropharmacology 22:1171-1176.
6. Carboni E, Imperato A, Perezzani L and Di Chiara G (1989) Amphetamine, cocaine, phencydidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats Neuroscience 28: 653-661.
7. Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotonic doses of methamphetamine. J Pharmacol Exp Ther 280:105-113.
8. Cheramy A, Leviel V and Glowinski J (1981) Dendritic release of dopamine in the substantia nigra. Nature (Lond.) 289:537-542.
9. Chesselet MF and Delfs JM (1996) Basal ganglia and movement disorders-an update. Trends Neurosci 19:417-422.
10. Cragg SJ and Greenfield SA (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci 17:5738-5746.
11. Cragg SJ, Hawkey CR and Greenfield SA (1997a) Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: Region and species differences. J Neurochem 69:2378-2386.
12. Cragg SJ, Rice ME and Greenfield SA (1997b) Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. J Neurophysiol 77:863-873.
13. Elverfors A, Jonason J, Jonason G and Nissbrandt H (1997) Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from superfused substantia nigra slices. Synapse 26:359-369.
14. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ and Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature (Lond) 380:252-255
15. Gerfen CR (1992) The neostriatal mosaic: Multiple levels of compartmental organization. Trends Neurosci 15:133-139.
16. Gerhardt GA, Oke AF, Nagy G, Moghaddam B and Adams RN (1984) Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res 290:390-395.
17. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (Lond) 379:606-612.
18. Groves PM and Under JC (1983) Dendro-dendritic synapses in substantia nigra: Descriptions based on analysis of serial sections. Exp Brain Res 49:209-217.
19. Hebert MA and Gerhardt GA (1997) Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther 282:760-768
20. Heeringa MJ and Abercrombie ED (1995) Biochemistry of somatodendritic dopamine release in substantia nigra: An in vivo comparison with striatal dopamine release. J Neurochem 65:192-200.
21. Hoffer BJ, Hoffman A, Bowenkamp K, Huettl P, Hudson J, Martin D, Lin LF and Gerhardt GA (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182:107-111.
22. Hoffman AF and Gerhardt GA (1998) In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: Effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions. J Neurochem 70:179-189.
23. Hoffman AF, Lupica CR and Gerhardt GA (1998) Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices. J Pharmacol Exp Ther.
24. Hoffman AF, van Home CG, Eken S, Hoffer BJ and Gerhardt GA (1997) In vivo microdialysis studies of somatodendritic dopamine release in the rat substantia nigra: Effects of unilateral 6-OHDA lesions and GDNF. Exp Neurol 147:130-141.
25. Iravani MM and Kruk ZL (1997) Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices. Synapse 25:93-102.
26. 3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: A comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine. J Pharmacol Exp Ther 262:356-364.
27. Kang Y and Kitai ST (1993) A whole cell patch-clamp study on the pacemaker potential in dopaminergic neurons of rat substantia nigra compacta. Neurosci Res 18:209-221.
28. Kawagoe KT, Zimmerman JB and Wightraan RM (1993) Principles of voltammetry and microelectrode surface states. J Neurosci Methods 48:225-240.
29. Kelly E, Jenner P and Marsden CD (1987) Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats. J Pharm Pharmacol 39:196-202.
30. LaHoste GJ and Marshall JF (1990) Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists. Behav Brain Res 38:233-242.
31. Nedergaard S, Bolam JP and Greenfield SA (1988) Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature (Lond) 333: 174-177.
32. Nirenberg MJ, Chan J, Liu Y, Edwards RH and Pickel VM (1996) Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites for somatodendritic storage and release of dopamine. J Neurosci 16:4135-4145.
33. Nissbrandt H and Hjorth S (1992) Dopaminergic neurotransmission in somatodendritic and terminal areas of the rat brain: Susceptibility to modulation by D1 and D2 receptors and to axotomy. J Neural Transm 90:13-26.
34. Nissbrandt H, Sundstrom E, Jonsson G, Hjorth S and Carlsson A (1989) Synthesis and release of dopamine in rat brain: Comparison between substantia nigra pars compacta, pars reticulata, and striatum. J Neurochem 52:1170-1182.
35. Osborne PG, O'Connor WT, Drew KL and Ungerstedt U (1990) An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats. J Neurosci Methods 34:99-105.
36. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
37. Rice ME, Cragg SJ and Greenfield SA (1997) Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. J Neurophysiol 77:853-862.
38. Rice ME, Richards CD, Nedergaard S, Hounsgaard J, Nicholson C and Greenfield SA (1994) Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp Brain Res 100:395-406.
39. Robertson GS, Damsma G and Fibiger HC (1991) Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J Neurosci 11:2209-2216.
40. Santiago M and Westerink BH (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn-Schmeidelberg's Arch Pharmakol 342:407-414.
41. Santiago M and Westerink BH (1991a) Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J Neurochem 57:738-747.
42. Santiago M and Westerink BH (1991b) The regulation of dopamine release from nigrostriatal neurons in conscious rats: The role of somatodendritic autoreceptors. Eur J Pharmacol 204:79-85.
43. Sesack SR, Aoki C and Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106.
44. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP and Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants. J Neurosci 17:960-974.
45. Westerink BH, Hofsteede RM, Tuntler J and De Vries JB (1989) Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J Neurochem 52:722-729.